Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Oncology Letters|June 29, 2012
Silencing Notch-1 induces apoptosis and increases the chemosensitivity of prostate cancer cells to docetaxel through Bcl-2 and BaxQi-Fa Ye, Yi-Chuan Zhang, Xiao-Qing Peng, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|September 28, 2007
Pedicled greater omentum flap for preventing bile leak in liver transplantation patients with poor biliary tract conditionsQi-Fa Ye, Ying Niu, Xing-Guo She, et al.
Oncology Reports|May 26, 2016
Effects of TMEM9 gene on cell progression in hepatocellular carcinoma by RNA interferenceYi Zhang, Yan Ran, Yan Xiong, et al.
World Journal of Gastroenterology|October 16, 2002
Combined small bowel and reduced auxiliary liver transplantation: case reportWei-Jie Zhang, Dun-Gui Liu, Qi-Fa Ye, et al.
Molecular Medicine Reports|November 3, 2018
Parkin deficiency elevates hepatic ischemia/reperfusion injury accompanying decreased mitochondrial autophagy, increased apoptosis, impaired DNA damage repair and altered cell cycle distributionXiao-Jie Ning, Xiong Yan, Yan-Feng Wang, et al.
Chinese Medical Journal|October 31, 2012
Risk factors for delayed graft function in cardiac death donor renal transplantsMing-Jie Shao, Qi-Fa Ye, Ying-Zi Ming, et al.
Chinese Medical Journal|August 9, 2013
Differences in willingness to donate cadaveric organ between young donor families and adult donor families: evidence from the Hunan Province, ChinaWen-zhao Xie, Qi-fa Ye, Wei Liu, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|November 6, 2003
Role of mitogen activated protein kinase cascade pathway and anti-stress response in liver transplantationNian-Qiao Gong, Jian-Sheng Xiao, Jin-Sheng Zeng, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|November 6, 2003
The value of color Doppler ultrasonography in monitoring normal orthotopic liver transplantation and postoperative complicationsDao-Zhong Huang, Gui-Rong Le, Qing-Ping Zhang, et al.
Theranostics|April 16, 2021
Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinomaFan-Hua Kong, Qi-Fa Ye, Xiong-Ying Miao, et al.
Pageof 6